SEC Form 4 · accession 0001518669-16-000006

Syneos Health, Inc. · SYNH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Executive Officer · Director

Period of report

Jul 20, 2016

Accepted (ET)

Jul 21, 2016 · 4:43 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001610950

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Class A Common Stock	Jul 20, 2016	M	29,586	$10.57	A	105,795	D
Class A Common Stock	Jul 20, 2016	S	29,586	$43.00	D	76,209	D
Class A Common Stock	Jul 20, 2016	M	71,007	$10.57	A	147,216	D
Class A Common Stock	Jul 20, 2016	S	71,007	$43.00	D	76,209	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy Class A Common Stock)^F2	$10.57	Jul 20, 2016	M	29,586	D	—	Jul 28, 2021	Class A Common Stock	29,586	90,449	D
Stock Option (Right to Buy Class A Common Stock)^F3	$10.57	Jul 20, 2016	M	71,007	D	—	Jan 1, 2023	Class A Common Stock	71,007	71,004	D

F1The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2016.
F2One half of the shares subject to this option vest yearly in five equal installments beginning on July 28, 2012, subject to continued employment. The other half of the shares subject to this option vest yearly in five equal installments beginning on December 31, 2013, subject to continued employment.
F3One half of the shares subject to this option vest yearly in five equal installments beginning on January 1, 2014, subject to continued employment. The other half of the shares subject to this option vest yearly in five equal installments beginning on December 31, 2013, subject to continued employment.